| Short Description : | Recombinant-HIV-II coat protein gp36-protein was developed from. For use in research applications. |
| Note: | STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | 0.2 µm filtered 100mM PBS, pH4.5, 10mM tris HCL, 8M Urea |
| Storage Instruction: | Can be stored in working aliquots at4°C C for one month, or at-20°C C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. NA |
| Endotoxin: | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg (1EU/µg). NA |
| Immunoreactivity: | Immunoreative with sera of infected HIV2 individuals NA |
| Immunogen: | Recombinant HIV-2 gp36 encodes the immunodominant sequences of the HIV2 surface Glycoprotein 36. NA |
| Immunogen Region: | Immunodominant sequences |
| Background | Recombinant HIV-2 Glycoprotein 36 contains an N terminal GST purification tag and migrates as an approximately 34 kDa protein under non-reducing conditions and reducing conditions in SDS-PAGE. |
Information sourced from Uniprot.org